{"name":"CF Pharma, LLC","slug":"cf-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5","date":"2026-02-13","type":"earnings","source":"Fierce Pharma","summary":"Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year - Fierce Pharma","headline":"Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOcGl1VW1CbE5Oc1h2cEhKNEU0cXhqX2sxdnhUVlRfZFROT1JXc2dDRzJ1M3JPckh4UzZWblFOeE5lNmhpQld5bDhXYTJvNGlXaTNQMjdXOVhSeS1jU045TzRkYV9WWnZaRnR1R1ppamxhbG14cjY0V2FOdzNRcGRkVGROcnJLYjQtRTBnUm5zd0gzY3BYYmtZVGRQLWlCVmZKWWk3UHdBYWZPZDNjOEhsZlVtSUlmQkxDUGo1czlwSlhBN0RNNXhV?oc=5","date":"2025-10-24","type":"deal","source":"Fierce Pharma","summary":"CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround - Fierce Pharma","headline":"CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPamlnRDNHRE96aVl3bzJUcXotdEx2ZEhtbHh4VTMxZ2ItVmpRX1JEbGd4eUVMazVqaFV3NG1vOXdSMnBpX0k2dTI5TzRUallIdFJCZkNIUWQ5eUhqWHA0cTNmbVZEeVFwRGhLeG9QZlRPTW5ibkZkVGtUQmtHV0hNc2hCYWxuVEZYYU9EQjNyS0dJWWdpNHBiYUY1VzVKTXEtMFRSd3hiUnJnaTd2UGFORFVYVmdranRJUnZNLXl2VXRiWmhQVDFzOC1VaUwtOVJhSGlBWA?oc=5","date":"2025-10-04","type":"pipeline","source":"respiratory-therapy.com","summary":"NHS England to Offer Alyftrek for Cystic Fibrosis - respiratory-therapy.com","headline":"NHS England to Offer Alyftrek for Cystic Fibrosis - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNb2RrVkFEVTljVndDUF8zZjBHV09TNzRUN3lRSl96UkZTVU1VZHRXdnJKN2pIeUxLbk9vVExXaXRNdWtlNS1rY0V1YS11NGpwWEJteWtjSGJROU5jcHRPQVhvU18wYk56aFNsNHFUejNsZWFfREF1VEg4MDQzWndYNVFyQmx5SEhyU1FLTmJwQ0t3aVJiMHNRMFR2TjdVbHRKTkl0LUMwNE1LaFpLYlZ2eXByYmx3YzZnZ2U0VW5oZl9QNFpWcXhV?oc=5","date":"2025-05-06","type":"trial","source":"Fierce Biotech","summary":"Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program - Fierce Biotech","headline":"Vertex pauses Moderna-partnered cystic fibrosis trial, takes $379M hit tied to separate program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5","date":"2025-05-06","type":"earnings","source":"Fierce Pharma","summary":"Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma","headline":"Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNRkhLSTBhRVRxdDRldi1CbzNMYmdjajktX0JkNm90STNyVURwejMzN0o2MGNiVmtUWDNXUGJoWi01S0d5NEZaNzZGVjhzcURkOUpEWDBxMGg1OXYtbXhzVElnTmY2aGJzN0ktci0yR2o4U1NhaGxNY1c1WXJ0dElaaVdtVWYxeVdSSEF4MEdCbmJLNXhnRHNCRUZiRGVOU0Z6ajJlOTE4S1Z6RFZrN3MyUzBEeVY0SWRPbHBEZzRoLUlFQlFPWE5ydnJtTy1QdzBIdXRZSl94T1U?oc=5","date":"2024-12-20","type":"regulatory","source":"Reuters","summary":"US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment - Reuters","headline":"US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOS3N5SkJ1TlhPNXhhdzliTVhZRW5BYWJKSW1WRDBOaC16cXA5MHdJdnpJakVCMGRDWGNvbHRPQllUM1BuWUt0ZVBKSzkzR2NIWHpVQ2tBa0pycjNWbTFDNFo3T2hERVFlamRqejI2SWZEYlJNVHZ3TmNnUDBqRGdBcjAwY1FyTHFBYm9EaXQxZVRLMnZBWDBCX3ZJV3NXa1NNWFFoTjNzMHBYMVMzTnFoVkRmTVBQUUo1M0ltZ0JoWUlOcUhPTEdhdnBCazBFNVVUYUczQ0trQkN3R3JfMEp6MG54Z1JmZw?oc=5","date":"2024-11-04","type":"earnings","source":"Reuters","summary":"Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength - Reuters","headline":"Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQOGJBMzVaSzRhcDY0ZFJjbVVCaDkzNjA0d285ZndYMXVINklTdkhNOFh2M1hQT19sYVRxOFBLUEp2MVNzVnNHalE1VGgya0xnZUx1UnBQUWFTOWhFXzdwWURQazcyRTBvY05YdHpfLWstLWlwTzhxeGFmU2ltOUlHbGhIMnljMkxHNEtYSXc4MHhkZjVPRlBDNFlQVS1NemtKMklqWXZLNmxsMVlsOUxxS2pDa1N2a1pVN0w4U3dwdExyQ0FlZmRvRnZGQUFjOEpKOUo3VmZSUEpEVVY0YU5jTF96cHY?oc=5","date":"2024-08-01","type":"regulatory","source":"Reuters","summary":"Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments - Reuters","headline":"Vertex Pharma raises annual revenue forecast on strong demand for its cystic fibrosis treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPbHB4bVdXa3dYaGdFUmFyVmRuQ05ZVXhvSklXdXR5WE1GOTdKSW5ieUJUanctZXhBMnU0S2JxQ0UxRkdyUXd0ZDRiTi1CVE82V3NYaGxxODZnVkRuYmE2WFFzWXpBTjUyZG55YnNaRVR1djdUWDBTT2p0NDN2YUlsazBROGZ1MnlabXBQRGxoM08wem4tSDRiTzg5dm03MEI3RENJMURpSkptYndzQWhQUTBrZm11cWtidFoxQTg0dw?oc=5","date":"2023-11-17","type":"deal","source":"respiratory-therapy.com","summary":"Raptor Pharma Acquires Quinsair to Treat Infections in CF - respiratory-therapy.com","headline":"Raptor Pharma Acquires Quinsair to Treat Infections in CF - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOR2I3d3NuR1NfN3lzOXBqNDR0Nm1PTXVuYzI3cnBOOFVoazJqeklDTW9VOGU2LXc2Q3UxX1dMcE9xaUIyM3Z1YTFScTVSVml2LTlYR0pib3ozYWh5QXBLNnlZOE9IZjFtY0t2LUF5dzZhcFMyTFdpaDg0ajN1TWNqVkxZX0FfdkhpUTN1U0NGU1ZOWDVzeGoyOVdvNjAxTHlpdzNqeGVqUURoUGQ0SnhocnUyV1U1aENZUkN1Qlp0ZE12N2JpWml1WGRSNGt6eTVGSDZucWxaTDZCMzh3Um1z?oc=5","date":"2023-11-10","type":"deal","source":"respiratory-therapy.com","summary":"Raptor Pharma Acquires Quinsair for Lung Infections Common in CF Patients - respiratory-therapy.com","headline":"Raptor Pharma Acquires Quinsair for Lung Infections Common in CF Patients - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNV3VrYjJxRjhJaXZMN2MzYzhsRW8tWFFTT0hRa1F6UllucWRaamFySm9LSWl1SUVhZGNHZGdGNzlVNXlaU1FJNXRTbHVxc01CT1d5NGlGY0J3bE13UnZieDZsNlVwbTVBUTNtVkJXY0FwUXdXMXVuUDNfYV80V0hUQzFvUUt6M2lqbllPanBiZFVOTmhKSjk1aEpjb0lXdUZMNnFHVFl5eEkydWtSWU0zWlkyd0VvMkc4enFvbjZxQktRMERkM3ViNWFxbHJmUlRzbWlGWlZUZw?oc=5","date":"2023-11-09","type":"trial","source":"respiratory-therapy.com","summary":"Arrowhead Pharma Pauses Cystic Fibrosis Drug Study - respiratory-therapy.com","headline":"Arrowhead Pharma Pauses Cystic Fibrosis Drug Study - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTFBXbU43NUVvQk9HbzEwRGNfLUlRRnVNOXpvRnJxaTNJOEFHOFlHYnZqOVdEUVlLT2stYW8tWkVJcHYtY2VrbDVZZmN6S19Lb05rUFUxcGxZb0dwMkpySTZqcFhfc2hqby11ZWo3NzY5aVBIT2M?oc=5","date":"2023-06-27","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Pharma 2023 Half-year review reveals winners and losers - drugdiscoverytrends.com","headline":"Pharma 2023 Half-year review reveals winners and losers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}